HomeContact
Subscribe to our Newsletter

Subscribe to the bimonthly newsletter with the latest on regenerative biology.

Products

The field of regenerative medicine is still new; not many tissue engineering products have so far been approved for clinical use. Progress is enormous but depends on the establishment of suitable legal frameworks. Check back frequently to obtain information on recently launched products related to this cutting-edge field of research and application.

title sort icon
510(k) clearance for Aesculap S4 Spinal System
ACE surgical plaster calcium sulface hemihydrate receives 510(k) clearance from FDA
Antisoma Granted U.S. Orphan Drug Status for AS1411 in Renal Cancer
Biomet Receives FDA Clearance of Disposable Spacer Molds for Knee Revision Surgery
CaReS®
Ceramics powder BioResorb® Macro Pore received FDA Approval
CMC Biopharmaceuticals receives EMEA Approval for In-market Manufacture
Depuy's Expedium Spine System received FDA Approval
Depuy's Vertebroplastic Radiopaque Bone Cement cleared by American FDA
Ebixa®, Extended Approval for the Treatment of Moderate Alzheimer’s Disease
European Commission Approves Genzyme's Myozyme(R)
Exelon® Granted EU Marketing Authorization As First Treatment For Dementia Associated With Parkinson's Disease By European Commission
FDA approves Euroresearch's BIOPAD® for wound treatment
FDA Approves New Treatment for Gastrointestinal and Kidney Cancer
FDA Approves the First Treatment for Dementia of Parkinson’s Disease
FDA celaerance for Tissue-Transâ?¢, a sterile syringe for transferring autologous fat
Immortalized retinal pigmentary epithelial cell lines and their applications
Innocoll, Inc. Receives FDA Approval For CollaGUARD(TM), A Collagen-Based Advanced Wound Care Product
Isotis Orthobiologics received permission by FDA to market DynaGraft® II Dental
Isotis' Connexus receives 510(k) clearance from FDA